Systematic Drug Repurposing Through Integrated Analysis of Regulatory, Clinical, and Real-World Evidence: A Retrospective Validation Study

Unlock the Future of Drug Repurposing with Proven Accuracy

Discover how the Basil platform is revolutionizing drug repurposing. Our systematic framework integrates global labels, submissions, clinical studies, pharmacovigilance, and other data to identify novel therapeutic indications with unmatched precision. Review our research paper to learn how to create a data-driven engine for asset maximization, regulatory success, and peak commercial value.

Key Findings:

- 100% accuracy in identifying the approved new indication within the top 3 candidates

- 45 potential therapeutic opportunities uncovered from over 60,000 data points

- 4x improvement in predictive accuracy compared to traditional, siloed pharmacovigilance analysis (100% vs. 24%)

Ready to dive deeper? Request your copy of the full research paper to explore the power of integrated data in drug repurposing and gain insights that could shape the future of pharmaceutical development.